Receptor-targeted gene delivery ViaFolate-conjugated polyethylenimine

AAPS Journal

Volumn 1, Issue 4, 1999, Pages

  Quo, Wenjin ^a   Lee, Robert J ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 53149131335     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Garin-Chesa P, Campbell I, Saigo PE, Lewis JLJ, Old, LJ, Rettig, WJ. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Am J Pathol. 1993;42:557-567.
2. Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Cancer. 1994;73:2432-2443.
3. Crippa F, Buraggi G, DiRe M, Gasparini M, Seregni E, Canervari S, Gadina M, Presti A, Marini A, Seccamani E. Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibody. Eur J Cancer. 1991;27:724.
4. Crippa F, Bolis G, Seregni E, Gavoni N, Scarfone G, Ferraris C, Buraggi G, Bombardiert E. Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody 1-131 MOv18: clinical results in patients with minimal residual disease of ovarian cancer. Eur J Cancer. 1995;31A: 686-690.
5. Casalini P, Luison E, Menard S, Colnaghi, MI, Paganelli G, Canervari S. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization. J Nucl Med. 1997;38:1378-1381.
6. Paganelli G, Belloni C, Magnani P, Zito F, Pasini A, Sassi I, Meroni M, Mariani M., Vignali M, Siccardi A, Fazio F. Two-step tumor targeting in ovarian cancer patients using biotinylated monoclonal antibodies and radioactive streptavidin. Eur J Nucl Med. 1992;19:322.
7. Molthoff C, Buist M, Kenemans P, Pinedo, H, Boven E. Experimental and clinical analysis of the characteristics of a chimeric monoclonal antibody, MOv18 reactive with an ovarian cancerassociated antigen. J Nucl Med. 1992;33:2000.
8. Leamon CP, Low PS. Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proc Natl Acad Sci U S A. 1991;88:5572-5576.
9. Lee RJ, Low PS. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J Biol Chem. 1994;269:3198-3204.
10. Lee RJ, Low PS. Folate-mediated tumor cell targeting of liposomeentrapped doxorubicin in vitro. Biochim Biophys Acta. 1994; 1233:134-144.
11. Lee RJ Huang L. Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J Biol Chem. 1996 ;271:8481-8487.
12. Lee R, Wang S, Low P. Measurement of endosomal pH following folate receptor-mediated endocytosis. Biochim Biophys Acta. 1996;1312:237-242.
13. Wang S, Lee RJ, Cauchon, G, Gorenstein DG Low PS. Delivery of antisense oligodeoxynucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol. Proc Natl Acad Sci U S A. 1995; 92: 3318-3322.
14. Ladino CA, Chari RVJ, Bourret LA, Kedersha NL, Goldmacher VS. Folate-maytansinoids: target-selective drugs of low molecular weight, Int. J Cancer. 1997;73:859-864.
15. Kranz DM, Patrick TA, Brigle KL, Spinella MJ, Roy EJ. Conjugates of folate and anti-T-cell receptor antibodies specifically target folate-receptor-positive tumor cells for lysis. Proc Natl Acad Sci USA. 1995;92:9057-9061.
16. Gottschalk S, Cristiano R, Smith L, Woo S. Folate receptor mediated DNA delivery into tumor cells: potosomal disruption results in enhanced gene expression. Gene Ther. 1994;1:185-191.
17. Mislick KA, Baldeschwieler JD, Kayyem JF, Meade TJ. Transfection of folate-polylysine DNA complexes: evidence for lysosomal delivery, Bioconjugate Chem. 1995;6:512-515.
18. Douglas J, Rogers B, Rosenfeld M, Michael S, Feng M, Curiel D. Targeted gene delivery by tropism-modified adenoviral vectors. Nature Biotech. 1996;14:1574-1578.
19. Li S, Deshmukh H, Huang L. Folate-mediated targeting of antisense oligodeoxynucleotides to ovarian cancer cells. Pharm Res. 1998;15:1540-1545.
20. Zanta M-A, Boussif O, Adib A, Behr J-P. In vitro gene delivery to hepatocytes with galactosylated polyethylenimine. Bioconjugate Chem. 1997;8:339-344.
21. Kircheis R, Kichler A, Wallner G, Kursa M, Ogris M, Felzmann T, Buchberger M, Wagner E. coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther. 1997;4:409-418.
22. 99mTc-HYNIC-folate, a novel receptor-based radiopharmaceutical for tumor imaging. J Nucl Med. 1999;40:1563-1569.
23. Ciuchi F. Nicola GD, Franz H., Gottarelli G, Mariani P, Bossi MGP, Spada GP. Self-recognition and self-assembly of folic acid salts: columnar liquid crystalline polymorphism and the column growth process. J Am Chem Soc. 1994; 116:7064-7071.